Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Refractive, Business and Innovation

PanOptix® Trifocal IOL

sponsored by Alcon

With several prospective clinical studies now complete, and the number of surgeons with experience of the platform increasing, the evidence base for Alcon's PanOptix® Trifocal IOL has grown considerably. In this clinical update, you can find an overview of recently published and presented PanOptix® safety and efficacy data from experienced surgeons, as well as a comparison with other IOL options available on the market.

Download the PDF here

© 2020 Alcon Inc. 06/20 US-ACP-2000166

Subscribe to The Ophthalmologist Newsletters

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine